These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11791088)

  • 1. Influence of transdermal estradiol in the regulation of leptin levels of postmenopausal women: a double-blind, placebo-controlled study.
    Cagnacci A; Malmusi S; Arangino S; Zanni A; Rovati L; Cagnacci P; Volpe A
    Menopause; 2002; 9(1):65-71. PubMed ID: 11791088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of administration of 17beta-oestradiol on serum leptin levels in healthy postmenopausal women.
    Elbers JM; de Roo GW; Popp-Snijders C; Nicolaas-Merkus A; Westerveen E; Joenje BW; Netelenbos JC
    Clin Endocrinol (Oxf); 1999 Oct; 51(4):449-54. PubMed ID: 10583311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin-1 and nitric oxide levels are related to cardiovascular risk factors but are not modified by estradiol replacement in healthy postmenopausal women. A cross-sectional and a randomized cross-over study.
    Cagnacci A; Tarquini R; Perfetto F; Arangino S; Zanni AL; Cagnacci P; Facchinetti F; Volpe A
    Maturitas; 2003 Feb; 44(2):117-24. PubMed ID: 12590007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma leptin in postmenopausal women with coronary artery disease: effect of transdermal 17beta-estradiol and intermittent medroxyprogesterone acetate.
    Os I; Os A; Abdelnoor M; Larsen A; Birkeland K; Westheim A
    Climacteric; 2003 Sep; 6(3):204-10. PubMed ID: 14567768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of oral and transdermal short-term estrogen therapy in postmenopausal women with metabolic syndrome.
    Chu MC; Cosper P; Nakhuda GS; Lobo RA
    Fertil Steril; 2006 Dec; 86(6):1669-75. PubMed ID: 17074346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects on serum lipid and leptin levels of three different doses of norethisterone continuously combined with a fixed dose of 17beta-estradiol for nasal administration in postmenopausal women: a controlled, double-blind study.
    Castelo-Branco C; Palacios S; Vázquez F; Villero J; Ferrer J; Ascaso C; Balasch J
    Fertil Steril; 2007 Aug; 88(2):383-9. PubMed ID: 17561009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of transdermal 17-beta-estradiol on glucose metabolism of postmenopausal women is evident during the oral but not the intravenous glucose administration.
    Cagnacci A; Tuveri F; Cirillo R; Setteneri AM; Melis GB; Volpe A
    Maturitas; 1997 Dec; 28(2):163-7. PubMed ID: 9522324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between 1 year oral and transdermal oestradiol and sequential norethisterone acetate on circulating concentrations of leptin in postmenopausal women.
    Laivuori H; Koistinen HA; Karonen SL; Cacciatore B; Ylikorkala O
    Hum Reprod; 2001 Aug; 16(8):1632-5. PubMed ID: 11473954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of peroral and transdermal oestrogen replacement therapy on glucose and insulin metabolism.
    Karjalainen A; Paassilta M; Heikkinen J; Bäckström AC; Savolainen M; Kesäniemi YA
    Clin Endocrinol (Oxf); 2001 Feb; 54(2):165-73. PubMed ID: 11207630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients.
    Miyazaki Y; Mahankali A; Wajcberg E; Bajaj M; Mandarino LJ; DeFronzo RA
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4312-9. PubMed ID: 15356026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of oral continuous 17beta-estradiol plus norethisterone acetate replacement therapy on abdominal subcutaneous fat, serum leptin levels and body composition.
    Yüksel H; Odabaşi AR; Demircan S; Karul A; Kozaci LD; Köseoğlu K; Kizilkaya K; Başak O
    Gynecol Endocrinol; 2006 Jul; 22(7):381-7. PubMed ID: 16864148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age, insulin, SHBG and sex steroids exert secondary influence on plasma leptin level in women.
    Milewicz T; Krzysiek J; Janczak-Saif A; Sztefko K; Krzyczkowska-Sendrakowska M
    Endokrynol Pol; 2005; 56(6):883-90. PubMed ID: 16821206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptin in postmenopausal women: influence of hormone therapy, insulin, and fat distribution.
    Gower BA; Nagy TR; Goran MI; Smith A; Kent E
    J Clin Endocrinol Metab; 2000 May; 85(5):1770-5. PubMed ID: 10843150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced fat mass and increased lean mass in response to 1 year of melatonin treatment in postmenopausal women: A randomized placebo-controlled trial.
    Amstrup AK; Sikjaer T; Pedersen SB; Heickendorff L; Mosekilde L; Rejnmark L
    Clin Endocrinol (Oxf); 2016 Mar; 84(3):342-7. PubMed ID: 26352863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of low doses of transdermal 17 beta-estradiol on carbohydrate metabolism in postmenopausal women.
    Cagnacci A; Soldani R; Carriero PL; Paoletti AM; Fioretti P; Melis GB
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1396-400. PubMed ID: 1317387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum leptin levels and body weight in postmenopausal women under transdermal hormone replacement therapy.
    Salbach B; Nawroth PP; Kübler W; von Holst Th; Salbach PB
    Eur J Med Res; 2000 Feb; 5(2):63-6. PubMed ID: 10720565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intranasal 17beta-estradiol on bone turnover and serum insulin-like growth factor I in postmenopausal women.
    Garnero P; Tsouderos Y; Marton I; Pelissier C; Varin C; Delmas PD
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2390-7. PubMed ID: 10404809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of a new 7-day transdermal estradiol patch versus placebo in hysterectomized women with postmenopausal complaints.
    von Holst T; Salbach B
    Maturitas; 2000 Feb; 34(2):143-53. PubMed ID: 10714909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose hormone therapy and carbohydrate metabolism.
    Li C; Samsioe G; Borgfeldt C; Bendahl PO; Wilawan K; Aberg A
    Fertil Steril; 2003 Mar; 79(3):550-5. PubMed ID: 12620438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin sensitivity during postmenopausal hormone replacement with transdermal estradiol and intrauterine levonorgestrel.
    Raudaskoski T; Tomás C; Laatikainen T
    Acta Obstet Gynecol Scand; 1999 Jul; 78(6):540-5. PubMed ID: 10376866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.